Stalevo
In brief
- You can buy Stalevo without a prescription in our pharmacy, with delivery available throughout the United Kingdom.
- Stalevo is used for the treatment of Parkinson's disease in adults experiencing motor fluctuations despite standard levodopa/DDCI therapy. It works as a combination of levodopa, carbidopa, and entacapone to improve motor control.
- The usual dosage of Stalevo is 1 tablet per dose, taken 3–7 times daily, adjusted for symptom control.
- The form of administration is a film-coated tablet for oral use.
- The effect of the medication begins within approximately 30–60 minutes.
- The duration of action is typically around 4–6 hours.
- It is advisable to avoid alcohol consumption while taking Stalevo.
- The most common side effect is dyskinesia (involuntary movements), and nausea is also common.
- Would you like to try Stalevo without a prescription?
Basic Stalevo information
- International nonproprietary name (INN): levodopa, carbidopa, entacapone
- Brand names available in the United Kingdom: Stalevo
- ATC code: N04BA03
- Forms and dosages: Film-coated tablets in several fixed-dose strengths (levodopa/carbidopa/entacapone 50/12.5/200 mg up to 200/50/200 mg)
- Manufacturers in the United Kingdom: Orion Pharma
- Registration status in the United Kingdom: Licensed by the MHRA; prescription only
- OTC / Rx classification: Prescription-only medicine (POM)
Everyday use and best practices
Understanding when to take Stalevo is essential for effectively managing Parkinson's symptoms. For many, morning dosing sets a positive tone for the day. It helps to alleviate stiffness and boost mobility right at the start. Conversely, evening doses can be beneficial for coping with nighttime symptoms, ensuring a more restful sleep. Patients frequently find that sticking to a consistent dosing schedule aligns seamlessly with their body’s rhythm. Stalevo can be consumed with or without food, offering some flexibility to the patients. However, maintaining consistency is pivotal. Taking the medication during meals might help in reducing potential nausea, yet it's essential to be cautious about the timing when it comes to high-protein meals. Such meals can delay the absorption of the medication, which may impact symptom control. It's advisable to engage in a conversation with one’s GP regarding dietary habits to optimise the medication's effectiveness.Safety priorities
While Stalevo can significantly improve quality of life for many, there are certain groups who should avoid this medication. Patients with known hypersensitivity to any components of Stalevo, those suffering from severe liver disease, or individuals with narrow-angle glaucoma are advised to steer clear. The Medicines and Healthcare products Regulatory Agency (MHRA) has highlighted that these conditions could heighten side effects, potentially leading to more severe complications. Additionally, engaging in activities that demand alertness, particularly tasks such as driving or operating heavy machinery, requires caution. Patients on Stalevo may experience side effects like dizziness or dyskinesia, which could hinder safety. Regular check-ins with healthcare providers can aid in evaluating fitness to drive and ensuring safety during such activities.Dosage and adjustments
When considering Stalevo, the prescribing regimen typically follows NHS guidelines that associate the dosage with the patient’s existing levodopa treatment. Stalevo replaces the existing levodopa/carbidopa doses, usually one tablet with each dose, and the strength is chosen to match the patient's current levodopa treatment. Each tablet contains 200 mg of entacapone, and no more than 10 tablets should be taken in a day. For elderly patients or those with multiple health complications, healthcare providers often recommend starting with lower doses. This cautious approach aims to ensure safety while maximising therapeutic effects. Regular follow-ups can facilitate necessary dosage adjustments, enhancing overall symptom management.What’s inside and how it works
Understanding the components and functionalities of Stalevo can raise questions: How does it work to alleviate symptoms of Parkinson's disease? What ingredients contribute to its effectiveness?
Ingredients overview
At the heart of Stalevo lies a unique blend of three active ingredients: levodopa, carbidopa, and entacapone. This combination doesn’t just function collectively; it works synergistically to enhance dopamine production in the brain.
Specifically:
- Levodopa: Converts to dopamine, directly addressing motor symptoms.
- Carbidopa: Prevents premature conversion of levodopa, ensuring more of it safely reaches the brain.
- Entacapone: Extends the effects of levodopa by inhibiting its breakdown.
Mechanism basics explained simply
By converting levodopa into dopamine, Stalevo directly tackles the motor challenges faced by those with Parkinson's disease. The role of carbidopa is critical; without it, much of the levodopa would be converted to dopamine before reaching the brain, limiting its efficacy.
Entacapone’s purpose adds a layer of effectiveness, prolonging the benefits of levodopa by preventing its rapid breakdown. This means that doses of Stalevo can lead to enhanced and more sustained motor performance.
Main indications
Approved uses
Stalevo is primarily indicated for adults diagnosed with Parkinson’s disease, particularly for those experiencing 'wearing off' symptoms even when on standard levodopa treatment. Stalevo is licensed by the MHRA for this use.
Off-label uses in UK clinics
While Stalevo's primary use targets Parkinson’s disease, there are instances where it may also be used off-label for other neurological symptoms or conditions. This should only occur under specialist supervision, ensuring safety and efficacy.
Patients are reminded to consult healthcare professionals to discuss these potential usages to monitor safety and effectiveness closely.
Interaction warnings
When taking Stalevo, understanding interactions is crucial. Are there certain foods or medications that could interfere with its effectiveness? Here’s what to look out for:
Food interactions
Patients need to be aware that certain food interactions can influence levodopa absorption. High-protein meals may hinder the drug's effectiveness. Moreover, alcohol consumption can heighten adverse effects, including dizziness, which shouldn’t be taken lightly.
Drug conflicts
Significant drug interactions may arise with non-selective MAO inhibitors or specific antidepressants, leading to serious health risks. The MHRA emphasises the importance of reporting any adverse effects through the Yellow Card scheme to aid in monitoring these occurrences.
Alternative choices
When managing Parkinson's disease, patients often seek alternatives to Stalevo. This includes medications such as Sinemet (levodopa/carbidopa) and Madopar (levodopa/benserazide). These options have various pros and cons, which makes choosing the right one a nuanced decision.
| Medication | Pros | Cons |
|---|---|---|
| Stalevo | Combined therapy | Potential side effects |
| Sinemet | Widely used | More doses needed |
| Madopar | Flexible dosing | May cause nausea |
Regulation snapshot
Stalevo is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) and is a prescription-only medicine (POM) in the UK. Suspected side effects can be reported through the Yellow Card scheme.
Frequently asked questions
Patients often have common questions about Stalevo. Here are some of the frequently asked enquiries and straightforward answers:
How long does it take for Stalevo to work?
Most patients start noticing the effects of Stalevo within a few hours. However, it can take several weeks to achieve optimal results.
Can I stop taking Stalevo suddenly?
Stopping Stalevo abruptly is not advisable. It's crucial to consult a healthcare provider for guidance on a safe tapering plan.
Is Stalevo available over the counter?
Stalevo is a prescription-only medicine (POM) in the UK. It cannot be bought over the counter.
Guidelines for proper use
When tasked with counselling patients on Stalevo, pharmacists should highlight the importance of adhering to the prescribed regimen. Regular follow-ups are vital to monitor treatment efficacy and potential side effects.
NHS patient support advice
Patients are encouraged to actively engage with their healthcare teams. Addressing any concerns about therapy is crucial for understanding dosage adjustments and managing side effects effectively. Open communication contributes significantly to a successful treatment journey.
| City | Region | Delivery Time |
|---|---|---|
| Manchester | North West | 9–21 days |
| London | London | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | Yorkshire | 9–21 days |
| Liverpool | North West | 9–21 days |
| Bristol | South West | 9–21 days |
| Sheffield | Yorkshire | 9–21 days |
| Newcastle | North East | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Nottingham | East Midlands | 9–21 days |
| Brighton | South East | 9–21 days |
| Coventry | West Midlands | 9–21 days |
| Derby | East Midlands | 9–21 days |
